HHS updates youth gender dysphoria evidence review
HHS released an updated November evidence review on youth gender dysphoria that authors defended amid backlash and which the department says updates a May report; HHS Secretary Robert F. Kennedy Jr. called prior “gender-affirming” interventions for minors harmful and “malpractice,” and Assistant Secretary for Health Brian Christine warned of long-term risks including loss of fertility. HHS says it invited groups including the Endocrine Society and the AAP to peer review the report but they declined, while the Endocrine Society responded that use of puberty blockers and hormones in youth is rare, cautious, and associated with improved well‑being; the author roster includes affiliations such as MIT, Duke, SEGM and the Manhattan Institute.
📌 Key Facts
- HHS released a November update to its evidence review on youth gender dysphoria, superseding a May report.
- HHS Secretary Robert F. Kennedy Jr. said prior 'gender-affirming' interventions for minors are harmful and called them 'malpractice.'
- Assistant Secretary for Health Brian Christine warned the review shows long-term risks — including potential loss of fertility — and described the report as a wake-up call.
- HHS spokesperson Andrew Nixon said the agency invited groups including the Endocrine Society and the American Academy of Pediatrics to peer review the document, but those groups declined to participate.
- The Endocrine Society provided a detailed statement to media asserting that youth use of puberty blockers and hormones is rare, is approached cautiously, and is associated with improved well‑being.
- The updated review lists authors and affiliations connected to institutions including MIT, Duke, SEGM, and the Manhattan Institute.
📊 Analysis & Commentary (3)
"A polemical critique arguing that HHS’s updated evidence review on youth gender dysphoria is politically driven, misreads sexual science, and reflects a broader cultural backlash—what the author terms 'male resentment'—that will harm evidence‑based care for trans youth."
"An opinion piece arguing that biological sex differences deserve an open, evidence‑based public and clinical discussion—particularly in light of HHS’s updated review on youth gender dysphoria—and warning against politicized suppression of scientific nuance."
"An opinion piece arguing that biological sex differences are real and policy‑relevant, urging a cautious, evidence‑based reappraisal of gender‑affirming practices and related policies (particularly for youth) rather than adopting ideologically driven approaches."
📰 Sources (2)
- Direct quotes from HHS Secretary Robert F. Kennedy Jr. calling prior "gender-affirming" interventions for minors harmful and labeling them "malpractice."
- Assistant Secretary for Health Brian Christine warns of long-term risks and loss of fertility, framing the report as a wake-up call.
- HHS spokesperson Andrew Nixon says the agency invited groups including the Endocrine Society and AAP to peer review; those groups declined to participate in the review.
- Endocrine Society provided a detailed statement to Fox asserting youth use of puberty blockers/hormones is rare, cautious, and associated with improved well-being.
- Additional detail on the author roster and affiliations (e.g., MIT, Duke, SEGM, Manhattan Institute) and confirmation that the November document updates the May report.